$39.99
Description
Fanttest 4-in-1 Rapid Antigen Test Kit (Nasal) COVID-19 / RSV / Influenza / A&B Very High SensitivityPack of 5 tests INTENDED USEThe COVID-19/RSV/Influenza A&B Antigen Test Kit is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2, respiratory syncytial, influenza A and influenza B viral nucleoprotein antigens in nasal swabs from subjects. The symptoms of respiratory viral infection due to SARS-CoV-2, respiratory syncytial, influenza can be similar. The test is intended as an aid in diagnosis of symptomatic individual meeting respiratory infection for SARS-CoV-2 (within the first 7 days of the onset of symptoms) and influenza A/B or Respiratory syncytial virus (RSV) (within the first 4 days of the onset of symptoms). This kit is intended for layperson’s home use in a non-laboratory environment. Test results of this kit are for clinical reference only. It is recommended that a comprehensive analysis of the disease be conducted based on clinical manifestations of patients and other laboratory tests. PRINCIPLEThe COVID-19/RSV/Influenza A&B Antigen Test Kit is a lateral flow immunoassay based on the principle of the double antibody sandwich technique. A monoclonal SARS-CoV-2/RSV/Influenza A&B antibody conjugated with colored microparticles and sprayed onto the conjugation pad is used as a detector. During the test, the SARSCoV-2/RSV/Influenza A&B antigen in the sample interacts with the SARS-CoV-2/RSV/Influenza A&B antibody conjugated with colored microparticles, creating an antigen-antibody labeled complex. This complex migrates on the membrane by capillary action up to the Test line where it is captured by the pre-coated monoclonal SARS-CoV-2/RSV/Influenza A&B antibodies. A colored test line (T) would be visible in the each result window if SARS-CoV-2/RSV/Influenza A&B antigens are present in the sample. The absence of the T line indicates a negative result. The control line (C) is for procedural control and should appear whenever the test procedure is being performed properly.
